Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies

In this post hoc analysis of the 63 patients with secondary bacteremia enrolled in the 3 omadacycline phase 3 studies of acute bacterial skin/skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP), we determined that omadacycline is a viable therapeutic option for appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakoulas, George, Eckburg, Paul B, Amodio-Groton, Maria, Manley, Amy, Tzanis, Evan, Das, Anita F, Noble, Robert, McGovern, Paul C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212941/
https://www.ncbi.nlm.nih.gov/pubmed/34160473
http://dx.doi.org/10.1093/ofid/ofab136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212941/
https://www.ncbi.nlm.nih.gov/pubmed/34160473
http://dx.doi.org/10.1093/ofid/ofab136

Ejemplares similares